Adverum Biotechnologies, Inc. (ADVM)

Adverum Biotechnologies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	170	76	58	173	1,057	744
Market Cap Growth	306.81%	31.60%	-66.54%	-83.65%	42.01%	275.72%
Enterprise Value	38	42	-37	-34	652	605
PE Ratio	-	-0.65	-0.37	-1.19	-8.99	-11.54
PS Ratio	-	21.13	-	23.03	-	2976.22
PB Ratio	0.93	0.91	0.32	0.55	2.43	4.25
P/FCF Ratio	-3.17	-0.83	-0.48	-1.40	-11.59	-10.88
P/OCF Ratio	-3.20	-0.84	-0.53	-1.60	-13.33	-15.13
EV/Sales Ratio	-	11.72	-	-4.51	-	2420.94
EV/EBITDA Ratio	-1.67	-0.42	0.26	0.24	-5.81	-9.62
EV/EBIT Ratio	-1.42	-0.36	0.24	0.23	-5.60	-9.39
EV/FCF Ratio	-1.75	-0.46	0.31	0.28	-7.16	-8.85
Debt / Equity Ratio	0.35	0.77	0.52	0.32	0.06	0.16
Debt / EBITDA Ratio	-0.66	-0.65	-0.65	-0.72	-0.23	-0.45
Debt / FCF Ratio	-0.69	-0.70	-0.78	-0.82	-0.29	-0.41
Quick Ratio	9.06	3.95	5.83	14.74	20.64	8.61
Current Ratio	9.24	4.13	5.91	14.88	20.82	9.06
Asset Turnover	0	0.02	0	0.02	0	0.00
Return on Equity (ROE)	-90.40%	-98.60%	-67.40%	-40.00%	-31.60%	-36.60%
Return on Assets (ROA)	-51.40%	-52.80%	-43.40%	-30.40%	-28.10%	-30.00%
Return on Capital (ROIC)	-48.97%	-83.72%	-57.12%	-35.02%	-25.61%	-33.74%
Earnings Yield	-66.57%	-154.06%	-267.40%	-84.25%	-11.12%	-8.67%
FCF Yield	-54.57%	-120.59%	-207.48%	-71.18%	-8.62%	-9.20%
Buyback Yield / Dilution	-64.30%	-1.58%	-1.24%	-15.14%	-32.83%	-4.44%
Total Shareholder Return	-64.30%	-1.58%	-1.24%	-15.14%	-32.83%	-4.44%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).